Cognitive Claims Stir Senators To Question FDA Supplement Regulation
This article was originally published in The Tan Sheet
Executive Summary
Senator McCaskill says FDA might “lack a systematic approach to preventing adulterated, mislabeled and fraudulent products from entering the market.” She and Senator Susan Collins ask FDA for a “detailed description” of the agency’s evaluation of medical and nutritional claims for supplements on the market.”
You may also be interested in...
McCaskill Not Sold On Retailer Exemption From Supplement AER Filing
FDA regulations exempt retailers from compiling supplement adverse event reports, even for products that bear a store brand. Private label firms or contract manufacturers are required to receive AERs linked to those products and to forward reports of serious events to FDA within 15 days.
California Bill To Age-Restrict Sales Of Diet Pills Further Along Than Other States’ Legislation
CA, MA and NJ legislatures remain in session with bills active proposing regulations similar to NY law effective 22 April requiring retailers, including online, to ask for proof of age when customers buying consumer health products containing ingredients labeled or promoted for weight loss and bodybuilding benefits appear younger than 18.
CRN Has Standing For Steep Hill To Climb Challenging New York's Age-Restricted Sales
Federal judge finds “misreading of the legislation” in CRN’s argument that state “restricts access based purely on what has been said about the product or its ingredients.” But standing to challenge “means that only CRN is positioned right now to go before the court on behalf of industry,” says CEO Steve Mister.